Javascript must be enabled to continue!
ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats
View through CrossRef
AngII (angiotensin II), ACE (angiotensin I-converting enzyme) and the AT1 receptor (AngII type 1 receptor) are associated with the inflammatory process and microvascular dysfunction of AKI (acute kidney injury) induced by renal I/R (ischaemia/reperfusion). However, Ang-(1–7) [angiotensin-(1–7)], ACE2 (angiotensin I-converting enzyme 2) and the Mas receptor also play a role in renal disease models. Therefore, in the present study, we have examined the renal profile of Ang-(1–7), ACE2 and the Mas receptor in renal I/R and compared them with that of AngII, ACE and the AT1 receptor. Male Wistar rats were submitted to left nephrectomy and ischaemia (45 min) followed by reperfusion (2 or 4 h) in the right kidney. At 4 h of reperfusion, renal AngII was increased (P<0.01) and renal Ang-(1–7) was decreased substantially (P<0.05), although plasma levels of both angiotensins were unchanged. In addition, renal I/R decreased the renal mRNA expression of renin (P<0.05), AT1 receptors (P<0.001) and ACE2 (P<0.05). At 2 and 4 h of reperfusion, renal ACE activity was reduced (P<0.05). On the other hand, renal expression of the Mas receptor was greatly increased at 4 h of reperfusion (P<0.01), which was confirmed by immunohistochemical and Western blot analysis. In conclusion, increased renal expression of the Mas receptor associated with changes in the RAS (renin–angiotensin system)-related peptidases support an important role for the ACE2–Ang-(1–7)–Mas axis in AKI.
Title: ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats
Description:
AngII (angiotensin II), ACE (angiotensin I-converting enzyme) and the AT1 receptor (AngII type 1 receptor) are associated with the inflammatory process and microvascular dysfunction of AKI (acute kidney injury) induced by renal I/R (ischaemia/reperfusion).
However, Ang-(1–7) [angiotensin-(1–7)], ACE2 (angiotensin I-converting enzyme 2) and the Mas receptor also play a role in renal disease models.
Therefore, in the present study, we have examined the renal profile of Ang-(1–7), ACE2 and the Mas receptor in renal I/R and compared them with that of AngII, ACE and the AT1 receptor.
Male Wistar rats were submitted to left nephrectomy and ischaemia (45 min) followed by reperfusion (2 or 4 h) in the right kidney.
At 4 h of reperfusion, renal AngII was increased (P<0.
01) and renal Ang-(1–7) was decreased substantially (P<0.
05), although plasma levels of both angiotensins were unchanged.
In addition, renal I/R decreased the renal mRNA expression of renin (P<0.
05), AT1 receptors (P<0.
001) and ACE2 (P<0.
05).
At 2 and 4 h of reperfusion, renal ACE activity was reduced (P<0.
05).
On the other hand, renal expression of the Mas receptor was greatly increased at 4 h of reperfusion (P<0.
01), which was confirmed by immunohistochemical and Western blot analysis.
In conclusion, increased renal expression of the Mas receptor associated with changes in the RAS (renin–angiotensin system)-related peptidases support an important role for the ACE2–Ang-(1–7)–Mas axis in AKI.
Related Results
Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)
Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)
Abstract
ACE2, a member of the angiotensin converting enzyme family, plays an irreplaceable role in the renin-angiotensin system. And the variations of ACE2 are regarded as...
GW24-e3004 Pitavastatin preconditioning reduces myocardium ischaemia/reperfusion injury through microvascular protection in mice
GW24-e3004 Pitavastatin preconditioning reduces myocardium ischaemia/reperfusion injury through microvascular protection in mice
Objectives
To examine whether Pitavastatin Preconditioning could effectively reduce ischaemia/reperfusion injury (IRI) and the underlying mechanisms involved.
...
GW24-e2211 Protective effects of aliskiren on ischaemia-reperfusion-induced renal injury in rats
GW24-e2211 Protective effects of aliskiren on ischaemia-reperfusion-induced renal injury in rats
Objectives
The protective effect of aliskiren on ischaemia-reperfusion (I/R) injury in the heart and brain has been reported. Whether or not the protective effect...
Exploring the role of glycans in the interaction of SARS-CoV-2 RBD and human receptor ACE2
Exploring the role of glycans in the interaction of SARS-CoV-2 RBD and human receptor ACE2
AbstractCOVID-19 is a highly infectious respiratory disease caused by the novel coronavirus SARS-CoV-2. It has become a global pandemic and its frequent mutations may pose new chal...
GW24-e1391 Angiotensin-(1-7) inhibits vascular calcification in rats
GW24-e1391 Angiotensin-(1-7) inhibits vascular calcification in rats
Objectives
Angiotensin-(1-7) [Ang-(1-7)] is a new bioactive heptapeptide in the renin-angiotensin system (RAS). It is produced mainly by the activity of angiotens...
e0078 The effect of acute atorvastatin on cardioprotection of ischaemic postconditioning in diabetes mellitus
e0078 The effect of acute atorvastatin on cardioprotection of ischaemic postconditioning in diabetes mellitus
Objective
This study was to investigate if the low dose of acute atorvastatin treatment could affect the cardioprotection of ischaemic post-conditioning (Ipost) i...
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Angiotensin II has been shown to be a potent agent in the acceleration of wound repair. Angiotensin (1‐7), a fragment of angiotensin II that is not hypertensive, was found to be co...
e0618 Effects of Rosuvastatin on plasma NO and ET-1 during myocardial ischaemia-reperfusion injury in rabbits
e0618 Effects of Rosuvastatin on plasma NO and ET-1 during myocardial ischaemia-reperfusion injury in rabbits
Objective
To study the change of endothelial function during myocardial ischaemia-reperfusion injury in rabbits and the effect of Rosuvastatin.
...

